Fifty ASA Class JII patients were divided randomly into two equal groups for induction of anaesthesia with diazepam 0.25 mg / kg, or midazolam 0.15 mg / kg. All subjects were premedicated with a narcotic and monitored by ECG, radial arterial catheter and a spirometer for measurement of minute ventilation. The QF interval (time period from the Q wave of the ECG to thefoot of the radial artery pulse), mean arterial pressure, heart rate and minute ventilation were recorded before, during and immediately after the induction of anaesthesia. Although mean arterial pressure fell slightly (6%) following midazolam, all other cardiovascular variables were stable in both groups. Minute ventilation was depressed to 70% of control by both drugs and nearly onehalf the diazepam patients complained of pain on injection compared with only,one midazolam patient. These data suggest that midazolam is a reasonable alternative to diazepam for induction of anaesthesia in the high-risk patient.
In the twenty years since McClish I described induction of anaesthesia in high-risk patients with the benzodiazepine, diazepam, the use of the drug for this purpose has been well documented. 2 -5 Recently, midazolam, a watersoluble imidazo-benzodiazepine with a relatively short half-life, 6 has been introduced in clinical anaesthesia practice. With midazolam's short half-life, the length of postoperative somnolence is reduced 7 and its water solubility attenuates venous irritation at the injection site 8 and produces a relatively rapid induction time. 9 The purpose of our study was to compare the ·M.D., Associate Professor. "M.D., Research Fellow. anaesthetic induction qualities of diazepam with the newer drug, midazolam, in patients with equivalent organ system impairment. METHODS Fifty ASA Class III patients, scheduled for non-cardiac surgery, were divided randomly into two groups for induction of anaesthesia either with diazepam 0.25 mg/kg or midazolam 0.15 mg/kg delivered via a peripheral vein over ten seconds. The subjects suffered from a variety of ailments with over 90070 of them possessing significant peripheral vascular or cardiac disease. All patients received morphine sulfate 0.15 mg/kg and glycopyrrolate 0.2 mg intramuscularly for premedication.
Cardiovascular function was measured from the continuous ECG for heart rate (HR) and dysrhythmias from a radial artery catheter for electronic mean arterial pressure (MAP) and from both the ECG and arterial waveforms for derivation of the QF interval -the time period from the Q wave of the ECG to the foot of the radial artery pulse. This variable, an abbreviated systolic time interval, is an indicator of myocardial 'pump' function and may be obtained beat to beat.lO Shortening of the QF interval indicates increased myocardial performance, while a lengthened interval suggests cardiac depression. The interval is only moderately susceptible to changes in cardiac loading and heart rate.
Respiratory minute volume (V E ) was extrapolated from a I5-second spirometry measurement. Apnoea was denoted by more than 15 seconds without a breath.
All cardiovascular and respiratory measurements were made (1) after a 5-minute 'equilibration' interval following placement of the monitors while the patients breathed 100070 oxygen, (2) induction of anaesthesia, and (3) immediately after loss of consciousness was obtained. Appropriate inhalation or intravenous agents were used for the subsequent maintenance of anaesthesia during which routine monitoring was performed.
Arterial blood gas measurements were done during the pre-induction control period and immediately after induction of anaesthesia. Induction of anaesthesia was considered complete when there was loss of voluntary movement in response to verbal commands and loss of eyelid reflex. The times for these events were recorded as well as the incidence of pain on injection of the induction agent.
Statistical methods included analysis of variance for the time to induction of anaesthesia, Student's t-test for cardiovascular variables, and Fisher's exact test for the incidence of apnoea and pain of injection.
Significance was assumed at P<0.05. All values are presented as the mean plus standard deviation. The investigation was approved by the hospital Human Research Committee.
RESULTS
There was no significant demographc difference between groups (Table 1) nor differences between groups in the preand postinduction arterial blood gas values. Initial cardiovascular and respiratory measurements were similar as well ( Table 2 ). Following the induction of anaesthesia, there was a statistically, but not clinically, significant fall in mean arterial pressure to 94.2% of the control value in the midazolam group (Table 3 ). The other cardiovascular variables, including the QF interval, remained stable, although minute ventilation fell significantly, and equally, to about 70% of the control value in both groups after induction. The incidence of apnoea was not statistically different between the groups (midazolam 20%; diazepam 32%).
Loss of consciousness occurred in 67.3 (SD 7.7) seconds with midazolam compared with 97.3 (SD 9.5) seconds after diazepam (P<0.05). The time to loss of lid reflex was similarly abbreviated with midazolam -80.9 (SD 9.5) vs. 105.9 (SD 8.1) seconds (P<0.05). In addition, the complaint of pain on injection was 48% in the diazepam group and only 4% in the midazolam patients (P<0.05).
DISCUSSION
In this study, in which the anaesthetic induction qualities of midazolam and diazepam in high-risk patients were compared, it has been shown that the water-soluble drug produces shorter induction times, nearly equal cardiovascular stability, and less venous irritation.
The anaesthetic induction times in our investigation were somewhat shorter than those described by Reeves et al. ll and Fragen and colleagues l2 in earlier studies. However, in this study the patients received a narcotic premedication and were older than the patients in those studies. Both opioid administration 13 and ageingl4 can abbreviate the anaesthetic induction time of midazolam. Cardiovascular stability following the administration of midazolam was comparable with diazepam except for a small, but significant, 6l1!o fall in MAP. This decrease has been reported previously 15 and is ascribed to a concomitant fall in systemic vascular resistance. 16 Nevertheless, the use of midazolam has produced haemodynamically stable anaesthesia in patients for heart surgeryl7 and in healthy subjects. 18 In our investigation, the QF interval remained constant during the induction of anaesthesia, an indication that ventricular performance was unaffected by either drug at the concentrations used. Apparently, the benzodiazepines produced little cardiac depression in the sick patients in our study which supports previous work which showed that systolic time intervals do not change during anaesthetic induction with midazolam in a healthy population. 19 The incidence of apnoea in our study was comparable with other reports for midazolam 20 and the equivalent fall in measured respiratory minute volume with midazolam and diazepam during induction of anaesthesia was expected from data of other experiments with the benzodiazepines. 2 • 21 The depressed respiration seen in our patients was of minimal clinical importance, since all were ventilated manually before endotracheal intubation.
Finally, there was significantly less venous irritation at the injection site by midazolam than with diazepam in our subjects (48l1!o vs. 4l1!o) , consistent with the findings of other studies. 8 
